Literature DB >> 3200827

Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.

R B Gaynor1, M D Kuwabara, F K Wu, J A Garcia, D Harrich, M Briskin, R Wall, D S Sigman.   

Abstract

The enhancer element of the human immunodeficiency virus type I (HIV-I) long terminal repeat (LTR) contains two copies of nearly identical sequences AGGGACTTTCC (3G sequence) and GGGGACTTTCC (4G sequence) that are important in transcriptional regulation. A single copy of the 4G sequence is found in the NF-kappa B site of the immunoglobulin kappa-chain enhancer. Only the 4G motif in the HIV enhancer is bound by cellular proteins in extracts prepared from unstimulated HeLa cells, whereas the 3G and 4G motifs are bound by factors in extracts prepared from HeLa cells treated with phorbol esters [phorbol 12-myristate 13-acetate (PMA)] and lymphoid cells. To determine if this change in binding to the HIV enhancer was due to phosphorylation of a cellular protein, partially purified PMA-treated HeLa nuclear extracts were digested with calf intestinal phosphatase. Phosphatase digestion of nuclear extracts from PMA-treated HeLa cells markedly decreased factor binding to the HIV enhancer. Accordingly, phosphorylation of the DNA binding protein itself, or an inhibitor protein present in the partially purified extract, must mediate binding to the recognition sequence. Binding studies confirmed that each of the enhancer sequences was capable of binding factors independent of the activity of the other site and that the HIV enhancer was occupied by only one factor at any one time. Chloramphenicol acetyltransferase assays using mutants in either one or both HIV enhancer repeats revealed that each site was capable of functioning as a tat-inducible enhancer element in PMA-treated HeLa cells. These results suggest that the 3G and 4G motifs in the HIV enhancer function independently and that duplication in the HIV enhancer augments activity by a mechanism distinct from cooperative binding of NF-kappa B.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3200827      PMCID: PMC282761          DOI: 10.1073/pnas.85.24.9406

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.

Authors:  M Siekevitz; S F Josephs; M Dukovich; N Peffer; F Wong-Staal; W C Greene
Journal:  Science       Date:  1987-12-11       Impact factor: 47.728

2.  Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.

Authors:  J W Pierce; M Lenardo; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene.

Authors:  D Picard; W Schaffner
Journal:  Nature       Date:  1984 Jan 5-11       Impact factor: 49.962

4.  Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10-phenanthroline-copper ion: Escherichia coli RNA polymerase-lac promoter complexes.

Authors:  M D Kuwabara; D S Sigman
Journal:  Biochemistry       Date:  1987-11-17       Impact factor: 3.162

5.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

6.  Characterization of a novel HTLV-infected cell line.

Authors:  H P Koeffler; I S Chen; D W Golde
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

7.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

8.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

9.  Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.

Authors:  J A Garcia; F K Wu; R Mitsuyasu; R B Gaynor
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter.

Authors:  H Dinter; R Chiu; M Imagawa; M Karin; K A Jones
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  17 in total

1.  Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products.

Authors:  C Muchardt; J S Seeler; A Nirula; D L Shurland; R B Gaynor
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Interaction of enhancer-binding protein EBP1 (NF-kappa B) with the human immunodeficiency virus type 1 enhancer.

Authors:  L Clark; J R Matthews; R T Hay
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins.

Authors:  P Ghazal; J Young; E Giulietti; C DeMattei; J Garcia; R Gaynor; R M Stenberg; J A Nelson
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 4.  Genome reading by the NF-κB transcription factors.

Authors:  Maria Carmen Mulero; Vivien Ya-Fan Wang; Tom Huxford; Gourisankar Ghosh
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

5.  Functional analysis of the long terminal repeats of Drosophila 1731 retrotransposon: promoter function and steroid regulation.

Authors:  P Ziarczyk; F Fourcade-Peronnet; S Simonart; C Maisonhaute; M Best-Belpomme
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

6.  Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene.

Authors:  F Kirchhoff; H W Kestler; R C Desrosiers
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat.

Authors:  C Li; C F Lai; D S Sigman; R B Gaynor
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.

Authors:  A V Moses; C Ibanez; R Gaynor; P Ghazal; J A Nelson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.

Authors:  W Phares; W Herr
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

10.  Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression.

Authors:  J S Seeler; C Muchardt; A Suessle; R B Gaynor
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.